Phathom Pharmaceuticals, Inc. (PHAT) Form 10-Q Quarterly Reports
Phathom Pharmaceuticals, Inc. (PHAT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PHAT
CIK: 1783183
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerDavid Verderami
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418114 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001193125-26-407696 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | 4 | 0001193125-26-385250 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001193125-26-324867 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001193125-26-324865 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002854 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-20 | — | SCHEDULE 13G/A Filing | 0001104659-26-085122 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | 4 | 0001193125-26-306165 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | 8-K | 0001193125-26-278533 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-22 | 4 | 0001193125-26-241984 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234891 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234572 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234568 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234567 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234566 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234564 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234563 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-19 | 8-K | 0001193125-26-234379 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001193125-26-193946 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001193125-26-193945 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-07 | — | DEFA14A | 0001193125-26-144578 | View SEC Doc Filr Page |
| ARS | 2026-04-07 | 2025-12-31 | ARS | 0001193125-26-144576 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-07 | 2026-05-19 | DEF 14A | 0001193125-26-144570 | View SEC Doc Filr Page |
| S-8 | 2026-03-27 | — | S-8 | 0001193125-26-128966 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-03-12 | — | SCHEDULE 13G Filing | 0001104659-26-027124 | View SEC Doc Filr Page |